Announcements Trials
Browse Landscape

Phase

Phase 2 20Phase 1/2 3Phase NA 2Phase 3 2Phase 4 1Phase 1 1

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2HR+/HER2- Advanced Breast Cancer 1

Interventions

Exercise 112Surveys and Questionnaires 55Early Intervention, Educational 49Methods 46Standard of Care 45Magnetic Resonance Spectroscopy 45Blood Specimen Collection 44Acupuncture Therapy 44Educational Status 43Radiotherapy 36Mammography 36Control Groups 31Therapeutics 29Counseling 29Psychiatric Rehabilitation 27Cyclophosphamide 27Sentinel Lymph Node Biopsy 25Biopsy 24Yoga 20Mastectomy, Segmental 20Resistance Training 19Palliative Care 18Neoadjuvant Therapy 18High-Energy Shock Waves 18Doxorubicin 18Cognitive Behavioral Therapy 18Magnetic Resonance Imaging 17Practice Guidelines as Topic 16Paclitaxel 16Trastuzumab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms × dalpiciclib × Clear all
NCT06810492 2025-03-17

The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment

Hubei Cancer Hospital

Phase NA Not yet recruiting
40 enrolled
Breast

Breast Neoplasms

NCT06605690 2024-09-20

An Exploratory Clinical Study of Dalpiciclib an&Amp;#39;d Letrozole Combined With Anlotinib Neoadjuvant Therapy in Stage II-III Postmenopausal HR+/HER2- Early Breast Cancer

The Affiliated Hospital Of Guizhou Medical University

Phase NA Not yet recruiting
30 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡